sulfur hexafluoride has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Z; Jing, Y; Li, P; Tian, X; Yang, Y; Yuan, J; Zhang, X; Zhou, N; Zhu, H | 1 |
1 other study(ies) available for sulfur hexafluoride and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Ultrasound-targeted microbubble destruction promotes myocardial angiogenesis and functional improvements in rat model of diabetic cardiomyopathy.
Topics: Animals; Contrast Media; Coronary Circulation; Coronary Vessels; Diabetic Cardiomyopathies; Echocardiography, Doppler, Color; Heart Rate; Male; Microbubbles; Microcirculation; Microvascular Density; Myocardium; Neovascularization, Physiologic; Phospholipids; Rats, Sprague-Dawley; Recovery of Function; Stroke Volume; Sulfur Hexafluoride; Ultrasonic Therapy; Ventricular Function, Left | 2021 |